Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Part the Cloud Translational Research for Alzheimer’s Disease Program: Combination Therapies Program (PTC-CTP)

    The PTC-CTP grant from the Alzheimer's Association funds biomarker-driven clinical trials testing combination therapies for Alzheimer’s disease and related dementias.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Part the Cloud Translational Research for Alzheimer’s Disease Program: Enable the Molecule for Artificial Intelligence-Discovered Programs (PTC-EM-AI) Funding Program

    PTC-EM-AI Funding Program supports researchers advancing AI-discovered therapies through lead optimization and IND-enabling work to develop disease-modifying treatments for Alzheimer’s and related dementias.

    Alzheimers AssociationDue Dec 15, 2026$1,000,000

    Tau Pipeline Enabling Program V (T-PEP)

    Tau Pipeline Enabling Program V (T-PEP) supports researchers developing therapeutic candidates targeting tau or related mechanisms to advance potential disease-modifying treatments for tauopathies.

    Alzheimers AssociationForecasted May 28, 2027$750,000Forecasted

    Prevention RFP - Alzheimer's Drug Discovery Foundation

    Prevention RFP - Alzheimer's Drug Discovery Foundation supports researchers and clinicians conducting human studies of targeted interventions, combination therapies, and drug choices to reduce dementia risk.

    Alzheimers Drug DiscoveryForecasted Dec 7, 2026· 21d$5,000,000Forecasted

    Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

    Use mouse models to test existing and investigational drugs for Alzheimer's; focus on drug repositioning and combo therapy development.

    HHS-NIH11Due Feb 8, 2027$5,000,000

    Thome Memorial Foundation Awards Program in Alzheimer’s Disease Drug Discovery Research

    Thome Memorial Foundation Awards Program in Alzheimer’s Disease Drug Discovery Research supports postdocs and early-career investigators studying drug discovery to improve Alzheimer’s therapies.

    HRIAForecasted Oct 13, 2027$275,000Forecasted